A Study of the Immune Response to Heplisav in Healthy Older Adults

NCT01999699 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: HEPLISAV

Sponsor

Dynavax Technologies Corporation

Collaborators

[object Object]